Balague C - Search Results

1

Rac mediates TNF-induced cytokine production via modulation of NF-kappaB.

Williams LM, Lali F, Willetts K, Balague C, Godessart N, Brennan F, Feldmann M, Foxwell BM. Williams LM, et al. Among authors: balague c. Mol Immunol. 2008 May;45(9):2446-54. doi: 10.1016/j.molimm.2007.12.011. Epub 2008 Feb 6. Mol Immunol. 2008. PMID: 18258304 Review.

2

Differential pharmacological behaviour of p38 inhibitors in regulating the LPS-induced TNF-α production in human and rat whole blood in vitro.

Pont-Giralt M, Godessart N, Balagué C. Pont-Giralt M, et al. Among authors: balague c. Inflammation. 2011 Apr;34(2):119-32. doi: 10.1007/s10753-010-9215-2. Inflammation. 2011. PMID: 20446028

3

Design, synthesis, and structure-activity relationships of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38 mitogen activated protein kinase.

Lumeras W, Caturla F, Vidal L, Esteve C, Balagué C, Orellana A, Domínguez M, Roca R, Huerta JM, Godessart N, Vidal B. Lumeras W, et al. Among authors: balague c. J Med Chem. 2009 Sep 10;52(17):5531-45. doi: 10.1021/jm9008604. J Med Chem. 2009. PMID: 19678708

4

Understanding autoimmune disease: new targets for drug discovery.

Balagué C, Kunkel SL, Godessart N. Balagué C, et al. Drug Discov Today. 2009 Oct;14(19-20):926-34. doi: 10.1016/j.drudis.2009.07.002. Epub 2009 Jul 23. Drug Discov Today. 2009. PMID: 19596080 Review.

5

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita.

Koga H, Kasprick A, López R, Aulí M, Pont M, Godessart N, Zillikens D, Bieber K, Ludwig RJ, Balagué C. Koga H, et al. Among authors: balague c. Front Immunol. 2018 Jul 12;9:1558. doi: 10.3389/fimmu.2018.01558. eCollection 2018. Front Immunol. 2018. PMID: 30050528 Free PMC article.

6

Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational study.

Balagué C, Pont M, Prats N, Godessart N. Balagué C, et al. Br J Pharmacol. 2012 Jun;166(4):1320-32. doi: 10.1111/j.1476-5381.2012.01836.x. Br J Pharmacol. 2012. PMID: 22229697 Free PMC article.

7

Novel triazolopyridylbenzamides as potent and selective p38α inhibitors.

Aiguadé J, Balagué C, Carranco I, Caturla F, Domínguez M, Eastwood P, Esteve C, González J, Lumeras W, Orellana A, Preciado S, Roca R, Vidal L, Vidal B. Aiguadé J, et al. Among authors: balague c. Bioorg Med Chem Lett. 2012 May 15;22(10):3431-6. doi: 10.1016/j.bmcl.2012.03.099. Epub 2012 Apr 4. Bioorg Med Chem Lett. 2012. PMID: 22521646

8

Indolin-2-one p38α inhibitors III: bioisosteric amide replacement.

Eastwood P, González J, Gómez E, Caturla F, Aguilar N, Mir M, Aiguadé J, Matassa V, Balagué C, Orellana A, Domínguez M. Eastwood P, et al. Among authors: balague c. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6253-7. doi: 10.1016/j.bmcl.2011.09.006. Epub 2011 Sep 10. Bioorg Med Chem Lett. 2011. PMID: 21958544

9

1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase.

Lumeras W, Vidal L, Vidal B, Balagué C, Orellana A, Maldonado M, Domínguez M, Segarra V, Caturla F. Lumeras W, et al. Among authors: balague c. J Med Chem. 2011 Nov 24;54(22):7899-910. doi: 10.1021/jm200975u. Epub 2011 Oct 31. J Med Chem. 2011. PMID: 21999461

10

Indolin-2-one p38α inhibitors I: design, profiling and crystallographic binding mode.

Eastwood P, González J, Gómez E, Vidal B, Caturla F, Roca R, Balagué C, Orellana A, Domínguez M. Eastwood P, et al. Among authors: balague c. Bioorg Med Chem Lett. 2011 Jul 15;21(14):4130-3. doi: 10.1016/j.bmcl.2011.05.114. Epub 2011 Jun 6. Bioorg Med Chem Lett. 2011. PMID: 21696951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page